tm logo
DAYBUE
SEARCHED

on 24 Oct 2023

Last Applicant/ Owned by

ACADIA Pharmaceuticals, Inc.

12830 El Camino Real, Suite 400San Diego CA 92130

US

Serial Number

2197621 filed on 23rd Feb 2022

Correspondent Address

1000 RUE DE LA GAUCHETIERE OUESTBUREAU 3300MONTREAL

QUÉBEC

CA

H3B4W5

DAYBUE

Trademark usage description

pharmaceuticals for use in the prevention and treatment of neurologic, genetic, psychologic, and psychiatric diseases and disorders namely seizure dis Read More

Classification Information


Class [005]
Pharmaceuticals for use in the prevention and treatment of neurologic, genetic, psychologic, and psychiatric diseases and disorders namely seizure disorders, mood disorders, anxiety disorders, cognitive disorders, schizophrenia, psychoses, bipolar disorders, eating disorders, gambling addictions, drug addictions, internet addictions, Parkinson's disease, Alzheimer's disease, schizophrenia, chronic pain and glaucoma.


Classification kind code

11

Class [035]
Promoting awareness of patient support offerings for neurologic, genetic, psychologic, and psychiatric diseases and disorders; medical referrals.


Classification kind code

11

Class [042]
Scientific research in the field of neurologic, genetic, psychologic, and psychiatric diseases and disorders; research in the field of industrial biotechnology and biomedical research; chemical, biochemical and molecular biological analyses; providing medical and scientific research information in the field of pharmaceuticals and clinical trials.


Classification kind code

11

Class [044]
Medical consulting with respect to neurologic, genetic, psychologic, and psychiatric diseases and disorders, including Rett syndrome and its identification and treatment; providing online information in the field of neurologic, genetic, psychologic, and psychiatric diseases and disorders to health care providers, caregivers, and patients; medical informational support services, namely, providing information about the benefits of diagnostic tools, medical information regarding disease diagnosis, identification, treatment, and management, and healthcare-related information to patients, caregivers, and healthcare professionals all related to neurologic, genetic, psychologic, and psychiatric diseases and disorders; medical testing, namely, in vitro and in vivo preclinical testing of potential drugs; consultation related to medical testing, namely, in vitro and in vivo preclinical testing of potential drugs.


Classification kind code

11

Mark Details


Serial Number

2197621

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 30th Oct 2023
Agent Changed
Submitted for opposition 22
on 24th Oct 2023
Search Recorded
Submitted for opposition 20
on 24th Oct 2023
Examiner's First Report
Submitted for opposition 223
on 24th Oct 2023
Total Provisional Refusal
Submitted for opposition 256
on 15th May 2023
Notification of Possible Opposition Sent
Submitted for opposition 257
on 14th Jul 2022
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 13th Jul 2022
Created
Submitted for opposition 31
on 13th Jul 2022
Formalized
Submitted for opposition 30
on 23rd Feb 2022
Filed
Submitted for opposition 228
on 23rd Feb 2022
International Registration